Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice Chovi-Trull, Megias-Vericat, Santiago Bonanad Boix, Saturnino Haya Guaita, Ana Rosa Cid Haro, Marta Aguilar Rodriguez, Andres

Acquired haemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin: role of rituximab M. Á. Fernández de Palencia Espinosa, V. Arocas Casañ, B. Garrido Corro, A. de la Rubia Nieto

Vemurafenib for the treatment of BRAF V600 mutated glioblastoma: A case report Irene de la Fuente Villaverde, Alicia Caso González, Mónica Carbajales Álvarez, Alba Martínez Torrón, Sergio Fernández Lastras, Juan Luis García Llano, Ana Lozano Blázquez